These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
891 related articles for article (PubMed ID: 19702123)
61. Invited Commentary: Hormone therapy risks and benefits--The Women's Health Initiative findings and the postmenopausal estrogen timing hypothesis. Banks E; Canfell K Am J Epidemiol; 2009 Jul; 170(1):24-8. PubMed ID: 19468078 [TBL] [Abstract][Full Text] [Related]
62. [Renewing the recognition on benefit and risk of long-term hormone replacement therapy in postmenopausal women]. Zhang YW Zhonghua Fu Chan Ke Za Zhi; 2003 Aug; 38(8):487-8. PubMed ID: 14627037 [No Abstract] [Full Text] [Related]
63. [Menopause. Hormone substitution therapy and prevention of cardiovascular risk]. Grio R; Cellura A; Porpiglia M; Geranio R; Piacentino R Minerva Ginecol; 1998; 50(7-8):329-31. PubMed ID: 9808958 [TBL] [Abstract][Full Text] [Related]
64. [Hypertension and menopause]. Masszi G Orv Hetil; 2002 Dec; 143(51):2821-8. PubMed ID: 12638308 [TBL] [Abstract][Full Text] [Related]
65. Cardiovascular health in the menopausal woman: impact of the timing of hormone replacement therapy. Rosano G; Vitale C; Spoletini I; Fini M Climacteric; 2012 Aug; 15(4):299-305. PubMed ID: 22424090 [TBL] [Abstract][Full Text] [Related]
66. Cardiovascular health and the menopause: the gynecologist as the patients' interface. Arias RD Climacteric; 2006 Sep; 9 Suppl 1():6-12. PubMed ID: 16899438 [TBL] [Abstract][Full Text] [Related]
68. Effects of hormone therapy on blood pressure and the renin-angiotensin system in postmenopausal women. Prime DD; Brosnihan KB; Herrington DM Minerva Cardioangiol; 2007 Aug; 55(4):477-85. PubMed ID: 17653023 [TBL] [Abstract][Full Text] [Related]
69. [Cardiovascular effects of replacement hormones]. Kornitzer M; Hindlet JY Rev Med Brux; 1995; 16(4):285-90. PubMed ID: 7481244 [TBL] [Abstract][Full Text] [Related]
70. [Hormonal supplements for postmenopausal women: no evidence of protection against cardiovascular disease]. Stehouwer CD Ned Tijdschr Geneeskd; 2001 Jan; 145(2):61-4. PubMed ID: 11225257 [TBL] [Abstract][Full Text] [Related]
71. Cardiovascular disease in women: implications of hormone replacement therapy. Sarrel PM Int J Fertil Menopausal Stud; 1996; 41(2):90-3. PubMed ID: 8829704 [TBL] [Abstract][Full Text] [Related]
72. Effects of blood pressure reduction on cardiovascular risk estimates in hypertensive postmenopausal women. Preston RA Climacteric; 2007 Feb; 10 Suppl 1():32-41. PubMed ID: 17364596 [TBL] [Abstract][Full Text] [Related]
74. Are there second thoughts about the results of the WHI study? Haimov-Kochman R; Hochner-Celnikier D Acta Obstet Gynecol Scand; 2006; 85(4):387-93. PubMed ID: 16612699 [TBL] [Abstract][Full Text] [Related]
75. Hormone therapy and cardiovascular disease--still much to be learnt. Mikkola TS; Ylikorkala O Gynecol Endocrinol; 2005 Feb; 20(2):116-20. PubMed ID: 15823832 [TBL] [Abstract][Full Text] [Related]
77. [Alternative hormone therapy in postmenopause]. Fistonić I; Canić T; Duić Z; Fistonić M; Ciglar S Lijec Vjesn; 2006; 128(3-4):99-104. PubMed ID: 16808100 [TBL] [Abstract][Full Text] [Related]
78. The impact of tibolone and hormone therapy on serum C-reactive protein, tumor necrosis factor-alpha and hepatocyte growth factor in postmenopausal women. Sezer Ozer K; Erenus M; Yoldemir T Climacteric; 2009 Feb; 12(1):66-71. PubMed ID: 19012050 [TBL] [Abstract][Full Text] [Related]
79. WHI and aftermath: looking beyond the figures. Pines A Maturitas; 2005 May; 51(1):48-50. PubMed ID: 15883109 [TBL] [Abstract][Full Text] [Related]